New vaccine aims to protect pregnant women from malaria
NCT ID NCT02658253
First seen Dec 08, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This early-stage trial tested a new vaccine (PRIMVAC) designed to prevent malaria in pregnant women. It involved 68 healthy adults in France and Burkina Faso to check safety and immune response. Participants received three doses of the vaccine with different adjuvants to boost effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC 1417
Paris, 75679, France
-
CNRFP
Ouagadougou, BP 2208, Burkina Faso
Conditions
Explore the condition pages connected to this study.